SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-21-102855
Filing Date
2021-08-10
Accepted
2021-08-10 16:19:29
Documents
3
Period of Report
2021-08-09
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2124656d1_8k.htm 8-K 20395
2 EXHIBIT 99.1 tm2124656d1_ex99-1.htm EX-99.1 11018
3 GRAPHIC tm2124656d1_ex99-1img001.jpg GRAPHIC 4989
  Complete submission text file 0001104659-21-102855.txt   39785
Mailing Address ONE MAIN STREET, 10TH FLOOR CAMBRIDGE MA 02142
Business Address ONE MAIN STREET, 10TH FLOOR CAMBRIDGE MA 02142 617-417-5868
Black Diamond Therapeutics, Inc. (Filer) CIK: 0001701541 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39200 | Film No.: 211160188
SIC: 2836 Biological Products, (No Diagnostic Substances)
Office of Life Sciences